The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
TRANSENTERIX INC COM NEW 89366M201 750 510,142 SH   OTR   0 510,142 0
OCULAR THERAPEUTIX INC COM 67576A100 2,482 628,236 SH   OTR   0 628,236 0
CATABASIS PHARMACEUTICALS IN COM NEW 14875P206 1,689 285,765 SH   OTR   0 285,765 0
KALVISTA PHARMACEUTICALS INC COM 483497103 30,625 1,719,576 SH   OTR   0 1,719,576 0
DECIPHERA PHARMACEUTICALS INC COM 24344T101 28,005 449,951 SH   OTR 1,2 0 449,951 0
X4 PHARMACEUTICALS INC COM 98420X103 3,333 311,490 SH   OTR 1,2 0 311,490 0
AVROBIO INC COM 05455M100 28,528 1,417,204 SH   OTR 1,2 0 1,417,204 0
SUTRO BIOPHARMA INC COM 869367102 20,070 1,824,542 SH   OTR   0 1,824,542 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 18,061 1,915,274 SH   OTR 1,2 0 1,915,274 0
MISONIX, INC. COM 604871103 31,562 1,695,969 SH   OTR 1,2 0 1,695,969 0